Macrogenics Inc
Research Macrogenics Inc (MGNX) on Bullrun: market cap USD 236.76M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMGNX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 236.76M
- Financial periodQ2 2026
- RevenueUSD 32.83M
- Net incomeUSD 19.52M
- Free cash flow-USD 41.55M
Valuation Snapshot
latest market cap is USD 236.76M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 149.50M | -USD 74.62K | -USD 82.95M | 100.0% | -1.18 | USD 57.22M | USD 36.76M | USD 55.59M |
| FY2024 | USD 149.96M | -USD 66.97K | -USD 72.08M | 99.4% | -1.07 | USD 182.84M | USD 37.46M | USD 116.06M |
| FY2023 | USD 58.75M | -USD 9.06K | -USD 79.97M | 98.9% | -0.15 | USD 100.96M | USD 33.97M | USD 152.61M |
| FY2022 | USD 151.94M | -USD 119.76M | -USD 90.58M | 97.8% | -1.95 | USD 108.88M | USD 34.83M | USD 142.01M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 236.76M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 101.94M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 204.16M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 596.72M | 12.0 | n/a | n/a |
| 2022 | 2022-12-30 | USD 412.50M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 983.98M | n/a | n/a | n/a |
About Macrogenics Inc
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States.
Related stock research
Other Healthcare stocks
Aardvark Therapeutics Inc (AARD)
Abeona Therapeutics Inc (ABEO)
Acumen Pharmaceuticals Inc (ABOS)
Absci Corp (ABSI)
Arbutus Biopharma Corp (ABUS)
ABVC BioPharma Inc (ABVC)
Acadia Pharmaceuticals Inc (ACAD)
Adicet Bio Inc (ACET)
Achieve Life Sciences Inc (ACHV)
Alpha Cognition Inc (ACOG)
Aclaris Therapeutics Inc (ACRS)
Acrivon Therapeutics Inc (ACRV)
Frequently asked questions
What is Macrogenics Inc's market cap?
Macrogenics Inc's market capitalization is USD 236.76M.
What does Macrogenics Inc do?
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States.